NCT01136395
- Conditions
- DNA Virus Infections, Epstein-Barr Virus Infections, Herpesviridae Infections, +8 more
- Locations
-
- Department of Internal Medicine, University of Giessen Giessen, Germany
Clinical trial condition
Tumor Virus Infections
Explore clinical trials studying Tumor Virus Infections. Study availability and eligibility vary by location and protocol.
1,486 public trials
253 recruiting studies
Tumor Virus Infections trial results
NCT01529827
- Conditions
- Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, +179 more
- Locations
-
- Roswell Park Cancer Institute Buffalo, New York, United States
NCT01305200
- Conditions
- Bone Marrow Diseases, Burkitt Lymphoma, Childhood Acute Lymphoblastic Leukemia in Remission, +89 more
- Locations
-
- Children's Oncology Group Arcadia, California, United States
- City of Hope Duarte, California, United States
- Children's Hospital and Research Center at Oakland Oakland, California, United States
- Rady Children's Hospital - San Diego San Diego, California, United States
NCT00474929
- Conditions
- Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +44 more
- Locations
-
- Holden Comprehensive Cancer Center at University of Iowa Iowa City, Iowa, United States
- Mayo Clinic Cancer Center Rochester, Minnesota, United States
Completed
Donor T Cells After Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies
NCT01839916
- Conditions
- Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), +134 more
- Locations
-
- University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States
NCT02650466
- Conditions
- Common Warts, DNA Virus Infections, Infections, +8 more
- Locations
-
- Huntington Medical Foundation Pasadena, California, United States
Completed
Pembrolizumab and Ibrutinib in Treating Patients With Relapsed or Refractory Non-Hodgkin Lymphoma
NCT02950220
- Conditions
- B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Classical Hodgkin Lymphoma, Blood Protein Disorders, Burkitt Lymphoma, +46 more
- Locations
-
- Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
NCT01722305
- Conditions
- B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Burkitt Lymphoma, Burkitt Lymphoma, Central Nervous System Lymphoma, +23 more
- Locations
-
- Mayo Clinic in Arizona Scottsdale, Arizona, United States
- Mayo Clinic in Florida Jacksonville, Florida, United States
- Dana-Farber Harvard Cancer Center Boston, Massachusetts, United States
- Mayo Clinic Rochester, Minnesota, United States
NCT02631863
- Conditions
- Cervical Intraepithelial Neoplasia, Communicable Diseases, DNA Virus Infections, +22 more
- Locations
-
- Peking University People's Hospital Beijing, Beijing Municipality, China
- Qilu Hospital of Shandong University Jinan, Shandong, China
- The Obstetrics & Gynecology Hospital of Fudan University Shanghai, Shanghai Municipality, China
- Women's Hospital School of Medicine Zhejiang University Hangzhou, Zhejiang, China
NCT02000817
- Conditions
- Autoimmune Diseases, Cytokine Release Syndrome, DNA Virus Infections, +17 more
- Locations
-
- GSK Investigational Site Brussels, Belgium
- GSK Investigational Site Brussels, Belgium
- GSK Investigational Site Edegem, Belgium
- GSK Investigational Site Ghent, Belgium